Fluid Therapy Part II

download Fluid Therapy Part II

of 22

Transcript of Fluid Therapy Part II

  • 7/31/2019 Fluid Therapy Part II

    1/22

    126|C r i t i c a l C a r e

    LectureVI:FluidTherapy

    AndrewJRosenfeld,DVMABVP

    ElizabethDunphy,DVMAVECC

    Thegoalofthischapterisfortheteammembertogetabasicunderstandingofthe

    goals of intravenous therapy, how to calculate a fluid rate for the pet, how to monitor

    intravenousfluids,andhowtodiscusstreatmentconcernswiththeclient. Administration

    orchangestofluidtherapyshouldneverbedonewithoutproperinstructionandconsent

    fromtheveterinarian.

    It isessentialtohaveawelleducatedhospitalteamthatcanmonitorapatienton

    intravenous fluids fordehydration, fluidoverload,and fluid INS/OUTS. Inspecificcases

    where there are increased toxins in the blood stream secondary to renal disease, liver

    disease,certainformsofdiabetes,orothertoxicorsystemicdiseases;increasedamountsof

    fluids

    (1

    2

    x

    maintenance)

    can

    aid

    in

    removing

    toxins

    from

    the

    body

    (Diuresis).

    The

    goal

    of fluid maintenance is to provide support to aid in rehydration, maintenance and

    possibly diuresis for the pet. Fluid support is the key hallmark for stabilization in a

    majorityofemergencycare. Necessarysupplementsanddrugscanbeaddedtothefluid

    regimetoaidinthepetsrecovery. NutrientslikeDextroseandPotassium,andmedications

    like Metoclopramide, Lidocaine, and Dopamine, can be added to intravenous fluids to

    provideacontinuousrateofinfusion(CRI)oftheneededdrug.

    Typesoffluidsupport:

    Fluidsupportcanbegivenintwoforms,subcutaneousfluidsandintravenousfluids.

    Eachtypeofadministrationhasitsownstrengthsandweaknesstohelptheillpatient.

    SubcutaneousFluids:

    o General: Subcutaneousfluidsareamoderatetolargebolusoffluidsgivenunder

    theskintocreateafluidrepositorythatcanbeslowlyabsorbedbythepetovera

    36hourperiodoftime.

    o Indications:Subcutaneous fluidsaremeant forslowreplenishmentofthemild

    tomoderatelydehydratedpatient.Indicationsforutilizationcanbe:

    o Acutediseaseproducingmilddehydrationforexample:

    MildGastrointestinalDisease

    MildUpperRespiratoryInfections

  • 7/31/2019 Fluid Therapy Part II

    2/22

    127|C r i t i c a l C a r e

    o ChronicDisease: Subcutaneousfluidsareusedwithpetswithchronicdiseaseat

    regular intervalstohelpmaintaintheirhydration. Thesepatientsdiseasesare

    usually under control and the pets are eating, drinking and feeling well.

    Examplesofchronicdiseasewheresubcutaneousfluidscanbegivenare:

    Chronicrenaldisease

    Chronicliverdisease

    These fluids can be done in the hospital setting, or the owner can be taught to

    administersubcutaneousfluidsathome.

    Emergency Conditions: Although not as valuable as intravenous fluids in

    emergencysituations,subcutaneousfluidscanhelptomildlyrehydrateapatient

    thathassevereperfusionproblems. Oncesubcutaneousfluidsareadministered

    andabsorbed,aveinmaybemoreeasilycatheterized.

    Contraindications: Withproperadministrationofsubcutaneousfluids,thereare

    fewcontraindications. Howeversomeconcernsare:

    IntravenousFluidAdditives: Somecautionmustbeexercisedthatcertainfluid

    additives (i.e.dextrose), whicharenormallygiven intravenously,arenotgiven

    subcutaneously. Thesetypesoffluidadditivescancauseirritationanddamage

    totheoverlyingskin.

    Underlyingdiseaseconditions: Cautionshouldbeexercisedwithpatientsthat

    have underlying disease conditions that have the propensity for pulmonary

    edema. Although of much less concern then when using intravenous fluids,

    repeated subcutaneous fluids may increase the likelihood of buildup of fluid

    withinthelungfields. Someoftheseconditionsare:

    CongestiveHeartFailure

    SevereRenalDisease(EndStage)

    Drowning

    ElectricCordInjury

    Calculation

    of

    Fluid

    Need:

    The

    veterinarian

    will

    make

    recommendations

    for

    subcutaneous fluid boluses for the pet. However, the veterinary team should

    have an understanding of approximate fluid parameters to prevent

    miscommunicationoroveradministrationoffluids(SeeTable6.1).

  • 7/31/2019 Fluid Therapy Part II

    3/22

    128|C r i t i c a l C a r e

    Table6.1: GuidelinesforSubcutaneousFluidTherapy

    IntravenousFluids

    General: Intravenous fluids are one of the hallmark treatments for the

    hospitalizedandemergencycarepatients inpractice. Teammembersmustbe

    ableto:

    Masterevaluatingdehydration

    Understand the benefits and concerns with different fluid types (i.e.

    crystalloidsvs.colloids)

    Understandinghowtocalculatefluidneed

    Monitoringapatientonintravenousfluids

    Properlydocumentingthefluidadministration

    Therearetwolargergroupsofintravenousfluidchoices,theyare:

    Crystalloids: Thiscategoryismadeupoftypesoffluidthathaveasimilar

    concentration(isotonic)densityasblood. Thegoalofthesefluids isfor

    long term intravenous administration for patients needing rehydration,

    dieresis,andemergencycare. Examplesofcommonlyusedcrystalloids

    are0.9%NaCl,LactatedRingersSolution(LRS),andNormosol

    Colloids: Thiscategoryismadeupoffluidtypesthathaveanincreased

    density (hypertonic) ascomparedtoblood. These fluidsareseparated

    into

    two

    further

    categories,

    which

    are:

    5These fluids are suggestion of fluid ranges based on pets weights. These

    ranges are meant for animals without primary disease that could produce

    pulmonary edema and congestion (i.e. Congestive Heart Failure, Electric

    Cord Injury).

    AnimalsWeight ApproxSubcutaneousFluidAmount5

  • 7/31/2019 Fluid Therapy Part II

    4/22

    129|C r i t i c a l C a r e

    o Natural Colloids: refer to blood, packed red blood cells and

    plasmathataremeantforbloodreplacementproductsinanemic

    orbleedinganimals.

    o SyntheticColloids: refertohypertonicsolutionsthatareusedfor

    shock and emergency patients to help increase systemic blood

    pressureorserveasabloodreplacementproduct. (Seebelow).

    ApplicationsandadministrationofIntravenousFluidsCrystalloids:

    General: Crystalloids are fluids containing electrolyte and non

    electrolytesolutescapableofenteringallbody fluidcompartments.

    They are the most common form of parenteral (nonoral) fluid

    therapy and are classified as replacement solutions (composition

    resembling extracellular fluid) or maintenance solutions (See Figure

    28.2). The choice of fluid depends upon the disease process. The

    most useful crystalloid solutions for routine use are balanced

    replacementsolutionssuchasRingersorLactatedRingersSolution,

    NormosolR,0.9%Salineand5%dextroseinwater.

    Indications: Crystalloid fluids are indicated for the treatment of ill

    patients that need rehydration, dieresis, or emergency care.

    Intravenoussupportcanbegivenoverhourstodayssafely. Nutrients

    such as dextrose and potassium chloride can be added to fluids to

    help provide minimal nutritional support as well as balance

    electrolytes. Further,drugs(suchasMetoclopramideandLidocaine)

    can be given for continuous administration (CRI continuous rate

    infusion)ofthesickpatient.

    Contraindications: Since intravenous fluidsprovideaconstant flow

    of liquid directly into the vein, caution must be exercised with

    patients with specific diseases. Careful monitoring is necessary for

    patientswithunderlyingdiseaseconditionsthathavethepropensity

    toproducepulmonary edema. Sincethesepetscannotcontrolthe

    rate

    at

    which

    fluids

    enter

    their

    body,

    the

    patients

    can

    become

    over

    hydrated and begin building up fluid within the lung tissue

    (pulmonarycongestion). Somediseasesthatrequirecautionare:

    CongestiveHeartFailure

    SevereRenalDisease(EndStage)

    DrowningElectricCordInjury

  • 7/31/2019 Fluid Therapy Part II

    5/22

    130|C r i t i c a l C a r e

    Further, animals that have diseases producing profound anemia or

    blood loss can be made worse with high volumes of intravenous

    fluids. These patients do not have enough red blood cells to carry

    oxygen

    to

    the

    body.

    If

    too

    much

    intravenous

    fluids

    are

    administered,

    the blood can become more dilute decreasing its oxygen carrying

    capacity. Somepotentialdiseaseproducingaseriousacuteorchronic

    anemia:

    ChronicRenalDisease(SeeChapterXIII)

    ChronicLiverDisease(SeeChapterXIV)

    BloodLoss/Trauma(SeeChapterXXX)

    AutoimmuneHemolyticAnemia

    CalculationofFluidNeed:

    General: Calculationoffluidneedisdependenton:

    Thepet

    Thedisease

    Fluidlosses(i.e.diarrheaandvomiting)

    Thepetslevelofdehydration

    Ifthepetisinshock

    The treatment amounts are up to the veterinarians recommendations. However, the

    team member must have a concept of the type, the daily fluid needsand rates of fluids

    given inordertomakesurethepet isgettinganadequateamountoffluidstorehydrate

    whilenotoverloading. Thecategoriesforrehydrationareasfollows:

    Maintenance: Maintenance fluids are the minimum amount of fluids needed

    giventoapetthatisnothavingsignificantfluidlosses(i.e.vomitingordiarrhea)

    tomaintainnormalhydration. Allanimalsrequire66ml/kg/dayfluidsforthe

    bodytofunctionnormally.

    Maintenance=BW

    (kg)

    x66

    ml/

    kg/

    day

    Dehydration: Dehydrationisaqualitativemeasurementofdehydrationlevelof

    the patient based on skin turgor, gums, eye appearance, and / or packed cell

    volume. AsdiscussedinChapterVI,dehydrationisbasedonthefollowingscale:

  • 7/31/2019 Fluid Therapy Part II

    6/22

    131|C r i t i c a l C a r e

    03%: Undetectable dehydration secondary to an animal that has been

    vomitingorhavingmilddiarrhea.

    57%:

    Beginning

    of

    detectable

    dehydration

    with

    slight

    decrease

    in

    skin

    turgorandbeginningofdrygums.

    79%:ismoreperceivabledehydrationwithmuchmoredecreasedelasticity

    ofskin,drygumsandsunkeneyes.

    912%:Lifethreateningdehydrationwithnoelasticityofskin,sunkeneyes,

    drygums,depressionandweakness.

    Calculatingfordehydrationusesthefollowingformula:

    Dehydration=%Dehydratedindecimalform x wt(kg)*1000ml/l

    Hourly fluid rate: Hourly fluid rate is calculated by taking total fluid need and

    dividingby24hrs/day. Formula:

    HourlyFluidRate=(TotalFluidNeed/day) / (24hours/day)

    BolusingFluids:

    Intimesofseveredehydration,priortoasurgeryortreatment,the

    doctor may want to give an intravenous bolus to help recap the fluid loss more

    quickly.Thereisnospecificamountoffluidsadministered;however,ageneralguide

    forbolusingpatientscanbe10 20%oftotalfluidforthatday.Theoverallbolusis

    subtracted from total fluid need and then hourly fluid rate is calculated. When

    bolusingfluids,thepatientmustbemonitoredforfluidoverload(seebelow).

    Tocalculatedropspersecond:

    Drops/Second=mls/second x drops/mls(dripsystem)

    ChronicityStrip: Oncedrops/secondiscalculated,achronicitystripcanbeusedto

    makesuretheanimalshourlyneedsarebeingcalculated(SeeFigure28.3).Thistype

    ofstrip,usuallymadeof1inchwhitetape,isplacedonabagoffluidsandthetimes

    are correlated with what the estimated fluid levels should be at that given time.

    Thisallowsthetechniciantheabilitytoadjustthefluidrateasitischeckedevery12

    hours.

  • 7/31/2019 Fluid Therapy Part II

    7/22

    132|C r i t i c a l C a r e

    SelectingIVFluidCare:

    FluidType Indicationsforuse Contraindications

    0.9%NaClRehydration,Diuresis,

    andMaintenance

    AcidoticPatients

    (Addisonians,Metabolic

    AcidosisPatients

    LRS(Lactated

    Ringer

    Solution)

    Rehydration,Diuresis,

    andMaintenance,

    HypocalcemiaPatient

    LiverPatient

    Normosol /

    Plasmalyte

    Rehydration,Diuresis,

    andMaintenance

    0.45NaCl&5%

    Dextrose

    Fluidsupportofthe

    cardiacpatientHYPOTENSION

  • 7/31/2019 Fluid Therapy Part II

    8/22

    IVFluidAdministrationAlgorithm

    Step I: Maintenance Fluids:

    ______Wt (kg) * 66 ml/kg/day = ________ ml/ day

    Step II: Dehydration:

    ______Wt (kg) * ____% Deny * 1

    Step III: Total Fluid Need (TFN)

    TFN = Maintenance = Dehydration

    Step III a: Bolus:

    Bolus = TFN * 0.2

    Step III b: recalculate TFN

    NEW TFN = TFN - Bolus

    WithFluidBolus

    Step IV: Hourly Rate (HR)

    Hourly Rate = TFN / 24 hrs

    WithoutFluidBolus

    St

    m

    Se

    D

  • 7/31/2019 Fluid Therapy Part II

    9/22

    134|C r i t i c a l C a r e

    Fluid Therapy for Shock: There are times when an animal is in a life threatening condition,

    shock,orcardiovascularshutdownwhenEmergencyFluidDosemayneedtobegiven. Atthis

    time,thispatientneedshighfluidvolumestomaintaintheirbloodpressureandcardiacoutput.

    Emergency dose of fluids are not associated or subtracted from daily need, they are given

    until

    normal

    perfusion

    and

    cardiac

    output

    are

    returned

    and

    the

    patient

    is

    no

    longer

    in

    shock.

    Generalguidelinesforemergencybolusesare:

    Dogs:90ml/kg/hr*wt(kg)

    Cats: 45ml/kg/hr*wt(kg)

    Duetothelifethreateningemergency,thesefluidsaregivenasquicklyaspossible,oftenwitha

    highpressurebagtomaximizefluidadministration(SeeFigure28.4).

    Itimportanttounderstandthattheseshockdosesrepresentthemaximumamountoffluidsa

    healthypetcanreceivein1hourbeforefluidbeginstobuildupwithinthetissue. Thereare

    many patients that cannot tolerate these large doses, and the animal must be closely

    monitoredforfluidoverloadwhileshockdosesarebeingadministered.

    Once the pet is stabilized, it is reevaluated by the veterinarian and hourly fluid rate is

    reassigneddependentondehydration,medicaldisease,andcurrentphysicalcondition. Please

    refertotable28.2foraroughoverviewoffluidneedbasedonthepatientsphysicalcondition.

  • 7/31/2019 Fluid Therapy Part II

    10/22

    135|C r i t i c a l C a r e

    Estimationoffluidadministrationneeddependentonhydrationandfluidlossstatus6

    Species Condition

    Significant

    V/D

    Suggested Fluid Administration

    Level

    Feline&Canine 05 % Dehydrated /Stable

    N Maintenance > 1 x

    Maintenance

    Feline&Canine 05 % Dehydrated /Stable

    Y Bolus+1 2x/Maintenance

    Feline&Canine 7 9 % Dehydrated /Stable

    N Bolus + Maintenance> 1 x

    Maintenance

    Feline&Canine 7 9 % Dehydrated /Stable

    Y Bolus+2xMaintenance

    Feline&Canine 912 %Dehydrated /Stable N Bolus+2xMaintenance

    Feline&Canine 912% Dehydrated /Stable

    Y Bolus+2x/Maintenance

    Feline Unstable YorN ShockFluidDoses(45ml/kg/hr)Canine Unstable YorN ShockFluidDoses(90ml/kg/hr)

    6 This table is a rough estimate of fluid need and should be only used as a reference source for the

    medical team member to ascertain the relative fluid level needed for a sick patient. All fluid

    administration rates are based solely on the veterinarian recommendations.

  • 7/31/2019 Fluid Therapy Part II

    11/22

    136|C r i t i c a l C a r e

    Complications Fluid Overload refers to the situation when an animal is receiving too many

    intravenousfluidsorreceiving fluids too quickly. If too much fluid is given, the excess

    fluidcanbegintopooloutsideofthevesselsandproducefluidbuildupinthetissue. Ifenough

    fluid

    accumulates

    in

    the

    lungs,

    the

    pet

    can

    drown.

    Signs

    of

    fluid

    overload:

    Clearnasaldischargeasfluidsarebeinggiven.

    Lickinglips

    Actingnauseous

    Fluidbuildupinfeetunderneckedema.

    Increasedrespiratoryeffortandrespiratorycracklesareevident.

    ApplicationsandadministrationofIntravenousFluidsColloids:

    General:

    Colloids are large macromolecular synthetic solutions (i.e. Hetastarch,

    Pentastarch)ornaturalsolutions(i.e.Blood,Plasma,PackedRedBloodCells)are

    used in the treatment of shock and the maintenance of intravascular fluid

    balance.

    Theselargedensemoleculesenterthebloodvesselsandincreasetheamountof

    fluiddrawnintothevesselsandresultinanincreasedbloodpressure. .

    Reducethe

    total

    fluid

    need

    of

    the

    patient

    by

    40

    60%.

    Therearetwocategoriesofcolloids:NaturalandSynthetic

    Naturalcolloidsincludewholeblood,plasmaproductsandalbumin.

    Syntheticcolloidsareformulatedfromvarioussources,suchasgelatins,

    polysaccharides(dextrans)oramylopectins(Hetastarch).

    Pharmacologicclassificationisbaseduponmolecularweight,plasmahalflifeand

    colloidoncoticpressure. Eachcolloidsolutionwithinthesegroupshasspecificcharacteristics, qualities and side effects, which must be considered in the

    selectionoftheappropriatetherapyforeachpatient.

    Indications: Colloidscanservetwooverallfunctions:

  • 7/31/2019 Fluid Therapy Part II

    12/22

    137|C r i t i c a l C a r e

    To increasefluiduptakeintothevesselsfromthetissue increasingbloodpressure.

    Thecolloidsgenerallyusedforthisfunctionare:

    Hetastarch

    Pentastarch

    To replace necessary blood factors needed for oxygenation of tissue, clotting of

    bloodandwoundhealing. Thecolloidsusedforthisfunctionare:

    PackedRedBloodCells:Servesasasourceofredbloodcellstohelpthepatient

    increasetheirpackedcellvolumeand increasetheoxygencarryingcapacityof

    theirblood.

    Plasma: is the fluid portion of blood whichcarries theproteins necessary for

    clotting blood. Further, plasma is rich in a protein called albumin, which

    maintains blood pressure by drawing water into the blood vessels as well.

    Withoutproperlevelsofalbumenintheblood,fluidcanpoolintotissuecausing

    edemaanddecreasingbloodpressure. Further,albuminisakeyproteinintissue

    healing.

    Contraindications: Each of these colloidshas their own limitationsdependenton

    thepatientscondition. Themaincontraindicationsare:

    Allergic Reaction: These chemicals can produce moderate to severe allergicreactioninthepet,andshouldalwaysbeadministeredslowlyinahospitalizedsituation.

    Dehydration: Further, since these drugs function also to pull fluid into the

    vascular supply, the pet must be reasonably hydrated before administration.

    Givingcolloidstoadehydratedanimalcanleadtofurtherdehydrationandpoor

    circulationas thebody is unable to move these largermolecules to the blood

    stream.

    Calculation of Fluid Need: The only colloid that will be discussed for calculation

    information is Hetastarch. Hetastarch is given in emergency cases when normal

    intravenous

    fluids

    are

    not

    returning

    normal

    perfusion

    and

    strong

    pulses

    to

    the

    shocky patient. As with all other fluid calculations, recommendations for fluid

    administrationaremadebytheveterinarian. However,inanemergencysituation,

    themedicalstaffshouldhaveanunderstandingoftheneedspatientandanticipated

    theveterinariantobereadytobegintreatmentofalifethreatenedpet.

  • 7/31/2019 Fluid Therapy Part II

    13/22

    138|C r i t i c a l C a r e

    ColloidType Reason Dose Concerns

    Hetastarch HypotensionFeline:11 15ml/kg/day

    Canine:1122ml/kg/day

    AllergicReaction

    CoreDehydration

    Tissue3rd

    Spacing

    Plasma ClottingFactors 1unit/20pounds AllergicReaction

    Plasma Hypoalbunemia45ml/kgtoraiseAlbumin

    1.0gm/dlAllergicReaction

    WholeBlood ActiveBleeding 1cc/lbtoraisePCV1%AllergicReaction

    Hemolysis

    PackedRedBloodCells Anemia/Bleeding1cc/poundtoraisePCV

    1.5%

    AllergicReaction

    Hemolysis

    Complications: Colloidscanproducemildtosevereallergic/ anaphylactic

    reactions to administration. Patients should be always maintained in a hospital

    settingunderdirectsupervision. Fluidsshouldbegivenslowlyinitiallytomakesure

    thepet isnothavinganyseverereaction,especially infelines.Although,this isan

    uncommon

    complication,

    the

    pet

    must

    be

    closely

    monitored

    for:

    Increasingdehydration

    IncreasedRespiratoryEffort

    IncreasingHeart/PulseRate

    Palingofthemucusmembranes

  • 7/31/2019 Fluid Therapy Part II

    14/22

    139|C r i t i c a l C a r e

    RespiratoryWheezing

    DecreasedMentation/Responsivity

    LateralorSternalRecumbence

    Collapse

    CardiopulmonaryArrest(SevereCases)

    Administration:

    Hetastarch can be administrated by a number of procedures. Two possible

    procedurescanbe:

    Smallpatient(

    Dosages(Oneofthefollowing):

    1) Volumetobetransfused=

    90ml(dog)or60ml(cat)X Recipient.BW(kg)X(DesiredPCVActualPCV)

    Donor'sPCV

    2) 1225ml/kg

    3) 2ml/kgwholebloodwithPCV40%willraiserecipienthematocrit1%

  • 7/31/2019 Fluid Therapy Part II

    15/22

    140|C r i t i c a l C a r e

    4) 1.0mlbloodper1lbrecipientweightwillraisePCVby1%

    Rate of administration: Start all transfusions at 0.25 ml/kg for first 15

    minutes

    to

    monitor

    for

    any

    transfusion

    reactions.

    Thereafter

    the

    rate

    can

    beincreasedto510ml/kg/hr,Bloodproductsshouldnotbegivenover

    morethan4hoursthough andmostpeoplesimplycalculatetherateof

    administrationbydividingthetotalvolumeneededby3or4hours.Care

    mustbetakenwiththosepatientsthatareatriskforfluidoverload.The

    maximumrateforsuchpatientsis4/mlIkglhr.

    Storage:Canineand felineRBCsareviable for34weeksdependingon

    theanticoagulantused. Wholebloodmustberefrigerated.

    Packedred

    blood

    cells

    (PRBC)Packedredbloodcellsare indicatedforanemiadueto

    bloodloss,hemolysis,andbonemarrowdysfunction.

    o Dosage:610ml/kg.

    o Rate of administration: Same as for all blood products. Start slowly at 0.25

    ml/kg/hrforthefirsthourandthenincreaseto510ml/kg/hr.

    o Storage:ThestorageofPRBCisthesameasthatforwholeblood.PRBCmustbe

    refrigeratedandareviableforapproximately3to4weeks.

    Plasma Fresh Frozen Plasma: Plasma transfusions are used to replace hemostatic

    proteins, namely the clotting factors, von Willebrands factor and fibrogen and

    fibronectin.Theproductsusedtoreplacehemostaticproteinsare:

    o FreshFrozenPlasma istypicallyusedasasourceofclottingfactors.Indications

    include hepatic dysfunction, anticoagulant rodenticide toxicity, hemophilia B,

    vonWillebrand'sdeficiencyandhemophiliaA(cryoprecipitateisabetterchoice

    though),andDIC.

  • 7/31/2019 Fluid Therapy Part II

    16/22

    141|C r i t i c a l C a r e

    FFPisnotareasonablechoicetoreplacealbuminthoughasthevolume

    ofplasmarequiredtocauseasignificantaffectonproteincounts isnot

    practical.Ittakes45ml/kgtoraisealbumin11g/dl.

    Dosage:

    610

    ml/kg

    Rate of administration: Similar to all blood products, start at 0.25

    ml/kg/hrtomonitorfortransfusionreactionsandthen increaseto510

    ml/kg/hr. As with PRBC, plasma should not be delivered over greater

    than4hours.

    Storage:FFPcanbestoredat 20DegreeCelsiusfor1year.

    Cryoprecipitate:

    Indicated in Hemophilia A, von Willebrand's Disease, generalized

    sepsis,DICandfibrinogendeficiency.TheadvantageofcryoprecipitateoverFFPisthat

    itsuserequiresamuchlowervolume,whichminimizestheriskofvolumeoverload.

    Dosage:1unit/10kgevery12hoursasneeded

    Storage:Canbestoredat 20degreesCelsiusforupto1year.

    Cryosupernatant: Indications for use the same as FFP with the exception of von

    Willebrand's disease, hemophilia and fibrinogen deficiency, as these factors are

    removedwiththecryoprecipitate.

    o Dosage:610ml/kg

    o Rateofadministration: Similartoallbloodproducts,startat0.25ml/kg/hrto

    monitor for transfusion reactionsand then increase to510m1/kg/hr.Aswith

    PRBC,plasmashouldnotbedeliveredovergreaterthan4hours.

    o Storage:Cryosupernatantcanbestoredat 20DegreeCelsiusfor1year;

  • 7/31/2019 Fluid Therapy Part II

    17/22

    142|C r i t i c a l C a r e

    ReplacementofPlatelets:Thereplacementofplateletsisverydifficulttosaytheleast.

    Itisnotdoneveryfrequentlysincethemajorcauseofthrombocytopeniainveterinary

    patients is Immune Mediated Thrombocytopenia and the transfused platelets are

    quicklydestroyed.Inaddition,theclinicalsignsofbleedingdonotusuallyoccurunless

    plateletcountisbelow50,000.Ifthehematocritisstableandanybleedingconsidered

    minimalthanthetransfusionofplateletsisrarelyindicated. Transfusingplateletsmay

    beindicatedpriortoasurgicalprocedure,ifanintracranialbleedissuspected,orwith

    plateletfunctiondefectssuchasNSAIDoverdose.Iftransfusingplateletsisdesired,than

    therearetwoavailablebloodproducts.

    o PlateletRichPlasma/PlateletConcentrateDosage:

    PRP610ml/kg

    PC1unit/10kg

    Platelet Phoresis is now a source of platelets. This process is able to greatly

    concentrateplateletssothat>1millionplateletsaretransfused.Theproductis

    veryexpensiveandcurrentlyneedstobeshippedinfromMidwestAnimalBlood

    Services.

    CrossmatchingandTransfusionReactions

    Blood types: Blood types are genetic markers on the erythrocyte surface that are

    antigenicandspeciesspecific.

    Dogs:

    Dogsdonothavetruebloodtypesasthetermisusedforhumansandcats.

    The dog instead has Dog Erythrocyte Antigens (DEA), which are numbered

    1.1,1.2,3,4,5,6,7,8.Clinicallythemostimportantare1.1,1.2andpossibly

    7.Dogscanbe1.1positiveornegative.

    IfDEA1.1negative,theycanthenbeDEA1.2positiveornegative.DEA1.1is

    stronglyantigenic.AfirsttimetransfusionofDEA1.1positivebloodtoaDEA

    1.1negativedogwillelicitastrongalloantibodyresponse.

  • 7/31/2019 Fluid Therapy Part II

    18/22

    143|C r i t i c a l C a r e

    These alloantibodies may not develop for up to 4 days and can cause a

    delayedtransfusionreaction.Apreviouslysensitizeddogcanhaveanacute

    hemolyticreaction.

    Cats:

    Likeeverythingelseinmedicine,catsaredifferentfromdogs.Catshaveonly

    3bloodtypes,ABandAB.

    These blood types have a unique inheritance pattern. The A allele is

    dominanttoBallele.TypeAcatsareeitherA/AorA/B.TypeBcatsmustbe

    B/B,ABisveryrareandinvolvestheinheritanceofa3rdallele.IntheUnited

    States

    Type

    A

    is

    the

    most

    common;

    the

    frequency

    of

    type

    A

    vs.

    B

    cats

    varies

    amongbreedsandgeographicalregions.

    In contrast to dogs cats have naturally occurringalloantibodies against the

    bloodtypeantigenthey lack, i.e.donotneedtobesensitized.TypeBcats

    haveverystronganti~Aantibodies.

    A transfusionofTypeA blood toa TypeB catwill result inaveryserious,

    acute hemolytic reaction, usually fatal. Cats can also have neonatal

    isoerythrolysis. (AI AB kittens receiving antiA antibodies from a type B

    mom'scolostrum.).

  • 7/31/2019 Fluid Therapy Part II

    19/22

    144|C r i t i c a l C a r e

    Blood typing techniques: In house cards are available that type dogs as DEA 1.1

    positiveornegativeaswellascardsthattypecatsasA,B,ABpositiveornegative.Blood

    canbesentouttospecializedlabstotypedogsDEA1.1,1.2,3,4,5,and7

    Crossmatching:

    Crossmatchingindicatestheserologiccompatibilityorincompatibilitybetweenthe

    donorandtherecipient.Alloantibodiescanbehemolyzingorhemoagglutinating.

    Amajorcrossmatchmeasuresalloantibodies intherecipient'splasmaagainst the

    donor's cells. A minor cross match measures alloantibodies in the donor's plasma

    againsttherecipient'scells,

    A previously transfused dog must have a crossmatch prior to an additional

    transfusion.Antibodies

    can

    be

    induced

    as

    quickly

    as

    4days

    and

    can

    be

    present

    for

    years.Adogthathastrulyneverbeentransfusedpotentiallycanskipacrossmatch

    butabloodtypeshouldbedone.

    Cats must be typed or crossmatched even on the first transfusion because of

    naturallyoccurringalloantibodies.

    AdministrationTechniques: Whenadministeringanycolloid,ahospitalprotocolshouldbeset

    upforadministrationofthefluid. Althoughhospitalsdiffer,onesuggestedprotocolis

    1. Maintain

    IV

    Fluids

    while

    a

    transfusion

    is

    being

    given: Maintaining IV fluids help to

    maintainhydrationanddecreasethelikelihoodoftransfusionreaction. Furtheritallows

    aportformedicationifneeded.

    2. Premedicate the patient: If the patient is set for receiving a natural colloid (blood,plasma,packedRBC)manyteamswillpremedicatepatientwithdiphenhydramine.

    3. Set a secondary IV catheter and begin transfusion of colloid: Have a teammember

    evaluatetheanimalevery5minutesforthe first3060minuteswhileatransfusion is

    being

    given.

    Each

    time

    the

    patients

    vitals

    are

    recorded

    and

    the

    patient

    is

    checked

    for:

    a. IncreasingHeartRate

    b. DecreasingPulseQuality

    c. Panting

  • 7/31/2019 Fluid Therapy Part II

    20/22

    145|C r i t i c a l C a r e

    d. IncreaseinBodyTemperature

    e. IncreaseinRespiratoryrate

    f. ChangeinMentation

    Ifnoted,thetransfusionistemporarilystoppedandtheveterinarianiscontacted

    immediately. Manytimesfluidrateswilloftenjustbeslowed.

    4. If transfusing whole blood or packed RBC: Team membersshould recheckPCV /TP

    when the transfusion is 50% completed. In some cases the animals PCV will

    dramatically increase above expected goals and to prevent colloid overload, the

    transfusionmayneedtobeslowedorstopped. Serumcolorshouldbeevaluated for

    hemolysisaswell.

    5. Continuethetransfusionoverthenext3hours: Ifnoreactionisnotedatthispoint,the

    transfusion rate should be continued over the next 3 hours. Team members should

    monitorthispatientevery1015minutesuntilthetransfusioniscompleted.

    6. If transfusing whole blood or packed RBC: Team membersshould recheckPCV /TP

    whenthetransfusion iscompletedtoevaluatefinaleffectoftransfusionandtosee if

    othertransfusionsmayberequiredinthefuture. Serumcolorshouldbeevaluatedfor

    hemolysisaswell.

    Transfusionreactions:

    Hemolysis

    Urticaria/edema

    Hypotension

    Treatment consists of immediately stopping the transfusion and administering short

    actingcorticosteroidsand/ordiphenhydramine.Seriousreactionsmayrequiretreating

    withepinephrine.

  • 7/31/2019 Fluid Therapy Part II

    21/22

    146|C r i t i c a l C a r e

    Nonimmunemediatedreactionsareusuallycausedbyhumanerror.Theseinclude:

    Circulatoryoverload

    Sepsisfromcontaminatedproduct

    Hypocalcemia

    Hemolysisfromcontactwithhypotonicsolutions

    Agglutinationfromcontactwithcalciumcontainingsolutions

    Diseasetransmission(Heartworm,Babesia,Hemobart,Ehrlichia,FELV,FIV)

    BloodCollection

    and

    Donor

    Selection

    AnticoagulantsCitrateactsasananticoagulantbyinhibitingcalciumdependentstepsof

    theclottingcascade,otheradditivesincludebuffersandredbloodcellenergysources.

    The2mostcommonanticoagulantsusedare:

    Citratephosphatedextroseadenine(CPDA): Usea1:9dilution,meaningadd1

    m1ofCPDAforevery9m1ofblood.WithCPDAcanineRBCsareviableforupto

    4weeks

    Acidcitratedextrose (ACD): Usea1:6dilution,meaningadd1m1of ACD for

    every6m1ofblood.WithACDcanineRBCsareviableupto3weeksandfeline

    RBCsareviableupto30days,

    CanineDonors:Theirweightshouldideallybegreaterthan25kgandtheirageideally2

    8yearsold. Thehematocritneedstobe>40%. Thedogsneedtobehealthyandfree

    frombloodbornediseaseswithaknownbloodtype. Ideally1.1,1.2and7shouldbe

    determined.FinallythedogsshouldhaveaknownvonWillebrandsfactorstatus

    Collection technique: Thejugular vein ispreferred for blood collection.Sterile

    techniques must be employed. The maximum donation for any one donor is

  • 7/31/2019 Fluid Therapy Part II

    22/22

    147|C r i t i c a l C a r e

    22ml/kgevery34weeks.Replacementfluidsarenecessaryifmorethan5%ofa

    donor'sbloodvolumeisdonated.Theuseofacommercialtriplepackcollection

    system is preferred. These bags contain the anticoagulant CPDA and a RBC

    nutritionsourcealreadyadded

    Feline:Theirweightshouldbegreaterthan5kgandtheiragebetween2and8years

    old.Thehematocritneedstobegreaterthan30%.Thecatsneedtobehealthyandfree

    frombloodbornediseasewithaknownbloodtype.

    Collection technique: Sedation is usually required when drawing blood from a

    donorcat.Asindogs,the betakerfromanyonedonoris15m/kgevery4weeks.

    NEVERtakemorethan60mlatonetimefromadonorcat.Frequentlythedose

    neededforthepatientisgreaterthan60ml,butunlessitisaverylargecat,60

    m1 isthemaximumamountacatcansafelydonateatonetime.Replacement

    fluidsarenecessaryifmorethan5%ofdonor'sbodyweightisdonated.